Results: OPTI

Search articles by EPIC code
EPIC OPTI
views

Optibiotix – what is the point of a lock in agreement? Even a signed agreement from Steve O'Hara is worth jack shit

I think Optibiotix (OPTI) shares are very cheap as are those of Skinbiotherapeutics (SBTX) and am a loyal shareholder in both expecting to treble my money from here. Nor do I begrudge Optibiotix selling a few shares in Skinbiotherapeutics as it announced it had today as I imagine that will more than pay for a Nasdaq listing which may drive a re-rate. But I suggest that, in light of today's events, a document signed by Steve O’Hara and Nomad and broker Cenkos is a worthless piece of toilet paper and both have legged over and deceived investors in Skinbiotherapeutics. Let me explain.

EPIC OPTI
views

OptiBiotix Health – strong commercial progress & company chat: this will be inflexion year: buy

OptiBiotix Health (OPTI) has announced a “Commercial strategy update” which shows strong progress in its strategy to initially build sales and brand presence and then move up the value chain by selling more product than ingredients and commercialising further compounds. We’ve also had a catch up chat with CEO Steve O'Hara. This should be THE YEAR when profits come close to or exceed £1 million.

Page 3 of 40 (395 articles)
Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Complete Coverage

Recent Comments

|